The Valens Company: Funding, Investors & Team (Sep 2026)
Valens Groworks is a biotechnology company that specializes in cannabis extraction, testing, analytics, and manufacturing. It focused on being the partner of choice for Canadian and international cannabis brands by providing proprietary services including CO2, ethanol, hydrocarbon, solvent-less and terpene extraction, analytical testing, formulation, and white-label product development. The company provides diverse extraction methods to develop premium products based on their needs. The Valens Groworks seeks to capture a broad spectrum of medical cannabis users, and adult recreational users once legalized, as well as clinical trial and R&D clients, in pursuit of its ambitious seed-to-sale and farm-to-pharma objectives. The company was founded in 2010 and headquartered in Kelowna, British Columbia.
The Valens Company has raised $31.2M across 1 funding round on record, the most recent a Post-IPO Debt of $31.2M announced in Dec 2021.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
The Valens Company Company Profile and Key Stats
Latest funding round on record: Dec 2021.
The Valens Company Funding Rounds
The Valens Company Founders and Leadership Team
Contact details for the The Valens Company team: 1 of 1 has an email address on file.
Start 14-day free trial →The Valens Company Funding Compared to Other Biotechnology Startups
The Valens Company's latest round of $31.2M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like The Valens Company in Biotechnology and Kelowna
Companies Similar to The Valens Company
Medicenna is a clinical-stage immunotherapy company focused on oncology and the development and…
Cybin is a clinical-stage biopharmaceutical company on a mission to create safe and effective…
Hemostemix Inc. is a Canadian biotechnology company that specializes in creating blood-derived cell therapies…
Avicanna is an organization in the biopharmaceutical sector that concentrates on enhancing medical cannabis…
Edesa Biotech is a privately-held company in the clinical stage that specializes in creating therapies for…
ME Therapeutics is a biotech company that specializes in finding and creating drugs for immuno-oncology that…
Aurinia Pharmaceuticals is a clinical stage biopharmaceutical company focused on developing and…
Medicus Pharma is a biotechnology research company that fast-tracks the progress of life sciences and…
ProteinQure is a biotechnology company specializing in creating innovative peptides for various medical…
Anodyne's mission is to create critical chemicals sustainably. Anodyne's approach takes advantage of nature's…
NervGen Pharma is a medicine company dedicated to creating solutions for the treatment of nerve damage and…
ZYUS is a biopharmaceutical company focused on providing patients with cannabinoids and other plant-based…
The Valens Company Funding FAQs
What does The Valens Company do?
Valens Groworks is a biotechnology company that specializes in cannabis extraction, testing, analytics, and manufacturing. It focused on being the partner of choice for Canadian and international cannabis brands by providing proprietary services including CO2, ethanol, hydrocarbon, solvent-less and terpene extraction, analytical testing, formulation, and white-label product development. The company provides diverse extraction methods to develop premium products based on their needs. The Valens Groworks seeks to capture a broad spectrum of medical cannabis users, and adult recreational users once legalized, as well as clinical trial and R&D clients, in pursuit of its ambitious seed-to-sale and farm-to-pharma objectives. The company was founded in 2010 and headquartered in Kelowna, British Columbia.
How much funding has The Valens Company raised?
The Valens Company has raised $31.2M across 1 round on record. The most recent is a Post-IPO Debt of $31.2M announced in Dec 2021.
When did The Valens Company last raise funding?
The Valens Company's most recent funding round on record is a Post-IPO Debt of $31.2M, announced in Dec 2021.
Who is the CEO of The Valens Company?
Tyler Robson is listed as CEO at The Valens Company.
Where is The Valens Company headquartered?
The Valens Company is based in Kelowna, British Columbia, Canada.
How many employees does The Valens Company have?
The Valens Company is in the 101-250 employee band.
How does The Valens Company's funding compare to other Biotechnology startups?
The Valens Company's latest round of $31.2M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's The Valens Company Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for The Valens Company is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.